Outset Medical, Inc.

Stage 4 · Declining · week 6

As of Oct 22, 2026, Outset Medical is in Stage 4, the downtrend phase, now in week 6 (since Sep 16, 2026). It closed at $4.17, 72.6% below its 52-week high and below its 200-day average, which is falling.

Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. More about the company

$4.17

+2.96% today

$78.4M · Micro cap

Market Neutral — Building

Pro read

Pro

Our read

Declining, below its long-term trend

Setup score

—

Momentum

Accelerating ⇈

Edge

—

Is OM early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…

Stage Cycle Timeline2023-08-16 → 2026-10-22

S4 21w

S4 16w

S4 14w

S1 13w

S4 31w

S1 15w

2023-08-162026-10-22

S1S2S3S4Setup score (0–10, dashed line at 5)

S4 21w → S1 2w → S4 16w → S1 9w → S2 2w → S3 1w → S4 14w → S1 13w → S4 12w → S1 1w → S2 12w → S3 7w → S4 31w → S1 15w → S2 1w → S3 2w → S4 5w current

Total tracked: 165 weeks across 17 stage runs.

OM among Medical Devices105th of 141 by relative strength

All 141 →

Stocks in Medical Devices ranked by relative strength, with stage and one-month change
#	Stock	Stage	RS	1M
1	TXG10x Genomics, Inc.	Stage 2 · wk 48	99	−7.8%
2	RCELAvita Medical, Inc.	Stage 2 · wk 13	98	+40.8%
3	BFLYButterfly Network, Inc. Class A	Stage 2 · wk 26	98	−26.0%
4	HAEHaemonetics Corporation	Stage 2 · wk 17	96	+8.7%
5	GKOSGlaukos Corporation	Stage 2 · wk 25	96	+15.1%
6	AXGNAxogen, Inc.	Stage 3 · wk 2	95	−15.3%
7	NEOGNeogen Corporation	Stage 2 · wk 14	95	−11.7%
8	BVSBioventus Inc. Class A	Stage 2 · wk 15	95	+10.5%
…105	OMOutset Medical, Inc.	Stage 4 · wk 6	14	+35.0%

vs 52W High

-72.6%

$2.96 lo$15.20 hi

72.6% below 52W high, deep Stage 4 damage

In Stage 4, distance from the 52-week high reflects an ongoing decline, not a discount.

Stage Maturity

Week 6

1w13w26w

Week 6, early Stage 4 decline

How long this stock has been in Stage 4 decline. The longer the downtrend, the more entrenched the selling pressure. No length of decline marks a bottom on its own.

vs 200 DMA

-0.1%

200 DMA: $4.17 · sloping down

In Stage 4, the stock is below its 200-day average, the hallmark of a downtrend. Stage analysis waits for that to reverse before buying.

Rel Volume

0.42x

vs 50-day avg

High volume on down days in Stage 4 confirms institutional selling. Low-volume bounces are typical. They lack real buyers and are easy to mistake for reversals.

Trend Health

↑ ⇈

Short-term trend rising strongly, and accelerating

Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.

+35.0%

+3.2%

-8.8%

YTD

+12.7%

-72.7%

Scan Membership

Breakout Watch

Latest: 2025-05-22

5 appearances in last 60 days. First seen: 2021-10-27.

A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding. Staying power in the scan says more about the trend than any single appearance.

Recent Stage Timeline

2026-10-22S4

Wk 6 · Vol 0.42x

2026-10-21S4

Wk 6 · Vol 0.45x

2026-10-20S4

Wk 5 · Vol 2.34x

2026-10-19S4

Wk 5 · Vol 0.36x

2026-10-16S4

Wk 5 · Vol 0.41x

2026-10-15S4

Wk 5 · Vol 0.32x

2026-10-14S4

Wk 5 · Vol 0.47x

2026-10-13S4

Wk 4 · Vol 0.40x

2026-10-12S4

Wk 4 · Vol 0.39x

2026-10-09S4

Wk 4 · Vol 0.43x

2026-10-08S4

Wk 4 · Vol 1.45x

2026-10-07S4

Wk 4 · Vol 0.81x

Moving averages & range

50 DMA

$3.75

200 DMA

$4.17

52W High

$15.20

52W Low

$2.96

5D Low

$3.80

Resistance levels (recent highs)

20d High

$4.22

60d High

$5.22

120d High

$5.22

250d High

$14.75

Next resistance

+1.2%

to 20d High

ROE

-59.2%

Profit margin -63.1%

Dividend Yield

0.00%

P/B 0.8

Outset Medical: quick answers

What stage is Outset Medical in?

As of Oct 22, 2026, Outset Medical (OM) is in Stage 4, the downtrend phase. It entered Stage 4 on Sep 16, 2026 and is in week 6. What the four stages mean

Is Outset Medical in an uptrend?

No. Outset Medical is in a Stage 4 downtrend. It trades 0.1% below its 200-day average, which is falling.

How far is Outset Medical from its 52-week high?

Outset Medical closed at $4.17 on Oct 22, 2026, 72.6% below its 52-week high of $15.20. Its 52-week low is $2.96.

How has Outset Medical performed over the past year?

As of Oct 22, 2026, Outset Medical is down 72.7% over the past year and up 12.7% so far in 2026.

Which sector and industry is Outset Medical in?

Outset Medical is in the Medical Devices industry, part of the Health Care sector.

About this companyHealth Care· Medical Devices

Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company provides Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also offers Tablo Data Ecosystem, including TabloHub, a consumer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.